Copyright 2018-2019 © BOLD Study

boldcentreuk (at) imperial.ac.uk 

Articles
 

2019

Burney P, et al. Association between chronic airflow obstruction and socio-economic position in Morocco: BOLD results. Int J Tuberc Lung Dis 2019; in press.

Janson C, et al. Bronchodilator reversibility in asthma and COPD: Findings from three large population studies. Eur Resp J; in press.

Triest FJJ, S et al. Airflow obstruction and cardio-metabolic comorbidities. COPD 2019;16(2):109-117.

Sakhamuri S, et al. Reduced forced vital capacity is independently associated with ethnicity, metabolic factors and respiratory symptoms in a Caribbean population: a cross-sectional study. BMC Pulmonary Medicine 2019;19(1):62.

Sator L, et alOverdiagnosis of COPD in subjects with unobstructed spirometry - a BOLD analysis. Chest 2019;156(2):277-288.

​​

2018

Razzaq S, et al. Epidemiology of asthma and associated factors in an urban Pakistani population: adult asthma study-Karachi. BMC Pulm Med 2018;18(1):184.

Brostrom E, et al. The prevalence of chronic airflow obstruction in three cities in the Nordic-Baltic region. Resp Med 2018;143:8-13.

Ahmed R, et al. A comparison of smartphone and paper data-collection tools in the Burden of Obstructive Lung Disease (BOLD) study in Gezira state, Sudan. PLOS One 2018;13(3):e0193917.

Amaral AFS, et al. Airflow obstruction and use of solid fuels for cooking or heating: BOLD results. Am J Resp Crit Care Med 2018;197(5):595-610.

2017

 

Mejza F, et al. Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study. Eur Resp J 2017;50(5):170062.

 

Grønseth R, et al. Unemployment in chronic airflow obstruction around the world: results from the BOLD study. Eur Resp J 2017; 50(3):1700499.

 

Coton S, et al. Severity of Airflow Obstruction in Chronic Obstructive Pulmonary Disease (COPD): Proposal for a New Classification. COPD; 14(5):469-475.

 

Horner A, et al. Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Resp Res 2017; 18:162.

 

Townend J, et al. The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Resp J 2017; 49:1601880.

 

Obaseki DO, et al. Reduced forced vital capacity in an African population: Prevalence and risk factors. Ann Am Thorac Soc 2017; 14(5):714-721.

2016

Denguezli M, et al. COPD in nonsmokers: Reports from the Tunisian population-based Burden of Obstructive Lung Disease study. PLoS ONE 2016; 11(3):e0151981.

 

El Rhazi K, et al. Prevalence of chronic obstructive pulmonary disease in Fez, Morocco: Results from the BOLD study. Int J Tuberculosis and Lung Dis 2016; 20(1):136-141.

 

Koul PA, et al. Prevalence of chronic airflow limitation in Kashmir, North India: Results from the BOLD study. Int J Tuberculosis and Lung Dis 2016; 20(10):1399-1404.

 

Loh LC, et al. Low prevalence of obstructive lung disease in a suburban population of Malaysia: A BOLD collaborative study. Respirology 2016; 21(6):1055-1061.

 

Meghji J, et al. Noncommunicable Lung Disease in Sub-Saharan Africa: A Community-based Cross-Sectional Study of Adults in Urban Malawi. Am J Respir Crit Care Med 2016; 194(1):67-76.

 

Obaseki DO, et al. Chronic Airflow Obstruction in a Black African Population: Results of BOLD Study, Ile-Ife, Nigeria. COPD: Journal of Chronic Obstructive Pulmonary Disease 2016; 13(1):42-49.

 

Vanfleteren LE, et al. Body mass index and chronic airflow limitation in a worldwide population-based study. Chron Respir Dis 2016; 13(2):90-101.

2015

 

Al Ghobain M, et al. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: A BOLD study. Int J Tuberculosis and Lung Dis 2015; 19(10):1252-1257.

 

Amaral AF, et al. Association of pulse wave velocity with total lung capacity: A cross-sectional analysis of the BOLD London study. Respir Med 2015; 109(12):1569-75.

 

Amaral AF, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J 2015; 46(4):1104-12.

 

Cooksley NAJB, et al. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study. Respirology 2015; 20(5):766-774.

 

Gnatiuc L, et al. Gaps In using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites. Int J Tuberculosis and Lung Dis 2015; 19(1):21-30.

 

Lamprecht B, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest 2015; 148(4):971-85.

 

Leidy NK, et al. Insight into Best Variables for COPD Case Identification: A Random Forests Analysis. Chronic Obstructive Pulmonary Diseases 2016; 3(1):406-418.

 

Niederseer D, et al.  Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study. Sleep and Breathing 2015; 19(3):pp 801-808.

 

Townend J, et al. Development of an international scale of socio-economic position based on household assets. Emerg Themes Epidemiol 2015;12:13.

2014

 

Burney P, et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis--authors' reply. Thorax 2014; 69(9):869-70, [Letter]

 

Burney P, et al. Chronic obstructive pulmonary disease mortality and prevalence: The associations with smoking and poverty-A BOLD analysis. Thorax 2014; 69(5):465-473.

Grønseth R, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Resp J 2014; 43(6):1610-20.

Gupta RP, et al. Summarising published results from spirometric surveys of COPD: The problem of inconsistent definitions. Int J Tuberculosis and Lung Dis 2014; 18(8):998-1003.

 

Ivey MA, et al. Assessing the performance of two lung age equations on the Australian population: using data from the cross-sectional BOLD-Australia study. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco 2014; 16(12):1629-37.

 

Pinto LM, et al. Derivation of normative data for the COPD assessment test (CAT). Resp Research 2014; 15:68

 

Sharifi H, et al. Burden of obstructive lung disease study in Tehran: Research design and lung spirometry protocol. Int J Preventive Med 2014; 5(11):1439-1445.

 

Sharifi H, et al. Interim report from burden of obstructive lung disease (BOLD study) in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease. Tanaffos 2014; 13(3):6-13.

 

Weiss G, et al. Detection of chronic obstructive pulmonary disease in primary care in Salzburg, Austria: Findings from the real world. Respiration 2014; 87(2):136-143.

2013

 

Arslan Z, et al. Prevalence of chronic obstructive pulmonary disease in Kocaeli: An industrialised city in Turkey. Balkan Med J 2013; 30(4):387-393.

 

Barbara C, et al. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: The burden of obstructive lung disease study. Revista Portuguesa de Pneumologia 2013; 19(3):96-105.

 

Cardoso J, et al. Chronic obstructive pulmonary disease in Portugal: Pneumobil (1995) and 2002 prevalence studies revisited. Revista Portuguesa de Pneumologia 2013; 19(3):88-95.

 

Daldoul H, et al. Prevalence of COPD and tobacco smoking in Tunisia - Results from the BOLD study. Int J Environmental Research and Public Health 2013; 10(12):7257-7271.

 

Janson C, et al. The impact of COPD on health status: Findings from the BOLD study. Eur Respir J 2013; 42(6):1472-1483.

 

Jithoo A, et al. Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study. Eur Respir J 2013; 41(3):548-55.

Lamprecht B, et al. Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: A population-based analytical study. Primary Care Respir J 2013; 22(2):195-200.

 

Toelle BG, et al. Respiratory symptoms and illness in older Australians: The Burden of obstructive Lung Disease (BOLD) study. Med J Australia 2013; 198(3):144-148.

2012

 

Burney P. The Burden of Obstructive Lung Disease (BOLD) study prepares for African Surveys. Africa Health 2011; 33(2)12.

 

Danielsson P, et al. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden - the Burden of Obstructive Lung Disease (BOLD) study: Cross-sectional population-based study. Clin Respir J 2012; 6(2):120-127.

 

Emilsson OI, et al. Nocturnal gastroesophageal reflux, lung function and symptoms of obstructive sleep apnea: Results from an epidemiological survey. Respiratory Medicine 2012; 106(3):459-466.

 

Hooper R, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J 2012; 39(6):1343-1353.

 

Kato B, et al. Can spirometric norms be set using pre- or post- bronchodilator test results in older people? Respiratory Research 2012; 13: 102.

 

Mannino DM, et al. Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis 2012; 16(10):1405-11.

 

Tan WC, et al. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax. 2012; 67(8):718-726.

 

Vanfleteren LEGW, et al. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Respir Med 2012; 106(6):871-874.

2011

 

Deveci F, et al. The prevalence of chronic obstructive pulmonary disease in Elazig, Eastern Turkey. Eur J Internal Med 2011; 22(2):172-176.

 

Enright P, et al. Quality of Spirometry tests performed by 9893 adults in 14 countries: The BOLD Study. Respiratory Medicine. 2011; 105(10):1507-1515.

 

Fjalldal SB, et al. Smoking, stages of change and decisional balance in Iceland and Sweden. Clin Respir J 2011; 5(2):76-83. 
 

Idolor LF, et al. Burden of obstructive lung disease in a rural setting in the Philippines. Respirology 2011; 16(7):1111-1118.

 

Lamprecht B, et al. COPD in never smokers: Results from the population-based burden of obstructive lung disease study. Chest 2011; 139(4):752-763.

 

Lamprecht B, et al. Subjects with discordant airways obstruction: Lost between spirometric definitions of COPD. Pulmonary Medicine 2011: 780215.

 

Schirnhofer L, et al. Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease. Respiration 2011; 81(6):476-482.

 

Tan WC, et al. Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada. Int J Tuberculosis and Lung Dis 2011; 15(12):1691-1696.

2010

 

Barry AC, et al. Exposure to indoor biomass fuel pollutants and asthma prevalence in Southeastern Kentucky: results from the Burden of Lung Disease (BOLD) study. J Asthma 2010; 47(7):735-41.

 

Prentice HA, et al. Significant bronchodilator responsiveness and "reversibility" in a population sample. COPD: Journal of Chronic Obstructive Pulmonary Disease 2010; 7(5):323-330.

2009

 

Jithoo A, et al. Implications of screening for COPD: Results from the Burden of Obstructive Lung Disease (BOLD) study from 14 countries. Thorax 2009; 64(Suppl IV:A32) & Thorax 2010; 65(1):91 [Erratum].

 

Margretardottir OB, et al. Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study. COPD 2009; 6(4):250-255.

 

Methvin JN, et al. COPD prevalence in Southeastern Kentucky: The burden of lung disease study. Chest 2009; 135(1):102-107.

 

Nielsen R, Johannessen A, Benediktsdottir B, Gislason T, Buist AS, Gulsvik A, Sullivane SD, Lee TA. Present and future costs of COPD in Iceland and Norway: Results from the BOLD study. Eur Respir J 2009; 34(4):850-857.

 

Perez-Padilla R, et al. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberculosis and Lung Dis 2009; 13(3):387-393.

 

Tan WC, et al. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ: Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne 2009, 180(8):814-820. 

 

Thorleifsson SJ, et al. Chronic airflow obstruction and markers of systemic inflammation: Results from the BOLD study in Iceland. Respir Med 2009; 103(10):1548-1553.

 

Vollmer WM, et al. Comparison of spirometry criteria for the diagnosis of COPD: Results from the BOLD study. Eur Respir J 2009; 34(3):588-597.

 

Zhou YM, et al. Current status of prevention and management of chronic obstructive pulmonary disease in rural area in China. Zhonghua nei ke za zhi [Chinese journal of internal medicine] 2009; 48(5):358-361.

2008

 

Buist AS, et al. Worldwide burden of COPD in high- and low-income countries. Part I. The Burden of Obstructive Lung Disease (BOLD) Initiative. Int J Tuberculosis and Lung Dis 2008; 12(7):703-708.

 

Geldmacher H, et al. The prevalence of chronic obstructive pulmonary disease (COPD) in Germany: Results of the BOLD Study. <Die pravalenz der chronisch obstruktiven lungenerkrankung (COPD) in Deutschland:
Ergebnisse der BOLD-Studie> Deutsche Medizinische Wochenschrift 2008; 133(50):2609-2614.

 

Hazen DA, et al. Gender specific differences in the pros and cons of smoking among current smokers in Eastern Kentucky: implications for future smoking cessation interventions. International Journal of Environmental Research and Public Health 2008; 5(4):230-242. 

 

Lamprecht B, et al. Non-reversible airway obstruction in never smokers: Results from the Austrian BOLD study. Respir Med 2008; 102(12):1833-1838.

 

2007

 

Benediktsdottir B, et al. Prevalence of COPD in Iceland--the BOLD study. Laeknabladid 2007, 93(6):471-477. 

 

Buist AS, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370(9589):741-750.

 

Firlei N, et al. The prevalence of COPD in Austria - The expected change over the next decade. <Die pravalenz der COPD in Osterreich - Die erwartete Entwicklung bis 2020. Wiener Klinische Wochenschrift 2007; 119(17-18):513-518.

 

Lamprecht B, et al. Farming and the prevalence of non-reversible airways obstruction - Results from a population-based study.  Amer J Industrial Med 2007; 50(6):421-426.

 

Lamprecht B, et al. Six-second spirometry for detection of airway obstruction: a population-based study in Austria. American Journal of Respiratory and Critical Care Medicine 2007, 176(5):460-464. 

 

Nizankowska-Mogilnicka E, et al. Prevalence of COPD and tobacco smoking in Malopolska region - Results from the BOLD Study in Poland. Polskie Archiwum Medycyny Wewnetrznej 2007; 117(9):402-410.

 

Schirnhofer L, et al. COPD prevalence in Salzburg, Austria: Results from the Burden of Obstructive Lung Disease (BOLD) study. Chest 2007; 131(1):29-36.

 

Zhong N, et al. Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey. Amer J Respir Crit Care Med 2007; 176(8):753-760.

 

2006

Rutten-van Molken M, Lee TA. Economic modeling in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2006; 3(7):630-634.

Zhou YM, et al. A study on the methodology regarding the prevalence survey of chronic obstructive pulmonary disease in China. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2006; 27(9):814-818.

 

2005

Buist AS, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): Rationale and design. COPD: Journal of Chronic Obstructive Pulmonary Disease 2005; 2(2):277-283.

Liu SM, et al. Epidemiologic analysis of COPD in Guangdong province. National Med J China 2005; 85(11):747-752.

Janson C, Malinovschi A, Amaral AFS, Accordini S, Bousquet J, Buist AS, Canonica GW, Dahlén B, Garcia-Aymerich J, Gnatiuc L, Kowalski ML, Patel J, Tan W, Torén K, Zuberbier T, Burney P, Jarvis D. Bronchodilator reversibility in asthma and COPD: Findings from three large population studies. Eur Resp J; in press.

Burney P, Atassi M, Kava A, Nejjari C, Benjelloun M, El Biaze M, El Kinany K, Patel J, El Rhazi K. Association between chronic airflow obstruction and socio-economic position in Morocco: BOLD results. Int J Tuberc Lung Dis 2019; in press.